EVOKEarnings•globenewswire•
Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
Sentiment:Positive (75)
Summary
Q2 2025 Net Product Sales Increased 47% Year-over-Year to $3.8 Million Q2 2025 Net Product Sales Increased 47% Year-over-Year to $3.8 Million
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 14, 2025 by globenewswire